earn whittak corp lo angel base aerospac biotechnolog compani restructur sell oper report 2 6 million loss continu oper third quarter end juli 31 contrast profit 2 2 million period last year incom continu oper reduc non recur pretax charg 10 2 million includ 6 4 million expens incur variou effort maxim sharehold valu includ effort sell compani well 3 8 million cancel employe stock option part whittak recapit oper profit continu oper quarter rose 41 5 10 5 million sale increas 1 9 50 8 million whittak report neg sharehold equiti 57 8 million juli 31 charg equiti 280 9 million cash paid sharehold part restructur 2 8 million expens recapit